Global Financial Private Client, LLC Halozyme Therapeutics, Inc. Transaction History
Global Financial Private Client, LLC
- $262 Billion
- Q1 2025
A detailed history of Global Financial Private Client, LLC transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, Global Financial Private Client, LLC holds 19 shares of HALO stock, worth $1,149. This represents 0.0% of its overall portfolio holdings.
Number of Shares
19
Previous 5
280.0%
Holding current value
$1,149
Previous $239,000
407.11%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding HALO
# of Institutions
562Shares Held
124MCall Options Held
668KPut Options Held
259K-
Black Rock Inc. New York, NY17.6MShares$1.07 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.3MShares$803 Million0.01% of portfolio
-
State Street Corp Boston, MA7.18MShares$435 Million0.01% of portfolio
-
Snyder Capital Management L P San Francisco, CA4.17MShares$252 Million4.34% of portfolio
-
Bank Of America Corp Charlotte, NC3.45MShares$209 Million0.01% of portfolio
About HALOZYME THERAPEUTICS, INC.
- Ticker HALO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 139,288,992
- Market Cap $8.43B
- Description
- Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...